2019–2020 HIV and HCV diagnostics survey report

Details

• Corporate Authors:
  Association of Public Health Laboratories (U.S.) ; Centers for Disease Control and Prevention (U.S.)
• Description:
  Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) both cause infections of public health importance and have significant clinical impact on those infected. As of 2019, approximately 1.2 million individuals were living with HIV in the US and over 35,000 new cases were diagnosed annually. While incident HIV infections have been declining, HCV infections have been increasing. There were estimated to be 57,500 new HCV infections in 2019 and 2.4 million individuals in the US living with HCV between 2013 and 2016.
  
  Two national strategies exist to reduce the number of acute HIV and HCV infections in the US. The US Department of Health and Human Services (HHS) launched Ending the HIV Epidemic (EHE) in 2019 and in 2021 released the updated Viral Hepatitis National Strategic Plans for the United States: A Roadmap to Elimination (2021–2025). EHE seeks to reduce the number of acute HIV infections by 90% by 2030 through improved HIV diagnostics, prevention, treatment and response strategies. Similarly, the Hepatitis Plan seeks to reduce new HCV infections by 90% by 2030 with similar goals to prevent new infections, improve hepatitis-related outcomes, reduce viral hepatitis-related disparities and health inequities, improve surveillance and establish coordinated efforts among partners and stakeholders that address the viral hepatitis epidemics, including collaboration with HIV programmatic partners.
  
  Public health laboratories play a critical role in reaching these national goals by contributing to confirmatory testing, surveillance, genotyping and drug susceptibility testing.
  
  This project was 100% funded with federal funds from a federal program of $334,707. This publication was supported by Cooperative Agreement #NU60OE000104 from the US Centers for Disease Control and Prevention (CDC). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC or the Department of Health and Human Services.
  
  ID-2022March-HIV-and-HCV-Survey-Report.pdf
  
  
• Subjects:
  Hepatitis C/diagnosis HIV Infections/diagnosis
• Funding:
  Cooperative Agreement #NU60OE000104
• Pages in Document:
  32 numbered pages
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:26282f8f5d9e1214422c84dce273b22e01363d635ba07a7bdb70141b34791abb
• Download URL:
  https://stacks.cdc.gov/view/cdc/118267/cdc_118267_DS1.pdf
• File Type:
  [PDF - 1.20 MB ]